Mark D. Weinstein

584 total citations
23 papers, 463 citations indexed

About

Mark D. Weinstein is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Mark D. Weinstein has authored 23 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Mark D. Weinstein's work include Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Parvovirus B19 Infection Studies (3 papers). Mark D. Weinstein is often cited by papers focused on Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Parvovirus B19 Infection Studies (3 papers). Mark D. Weinstein collaborates with scholars based in United States, Slovakia and Malaysia. Mark D. Weinstein's co-authors include Brian Herndier, Andrew Blauvelt, Kuan‐Teh Jeang, Jan M. Orenstein, D Ganem, Oliver T. Keppler, Mark A. Goldsmith, Andreas Jekle, Dominique Schols and Erik De Clercq and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Mark D. Weinstein

18 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Weinstein United States 7 232 190 157 135 123 23 463
Ketty Gianesin Italy 12 133 0.6× 132 0.7× 121 0.8× 80 0.6× 106 0.9× 18 431
Leticia Kuri-Cervantes United States 12 123 0.5× 92 0.5× 234 1.5× 137 1.0× 439 3.6× 23 660
Aggrey Nyongo Kenya 11 221 1.0× 63 0.3× 60 0.4× 98 0.7× 46 0.4× 17 393
M.C. Maillot France 7 69 0.3× 88 0.5× 198 1.3× 67 0.5× 349 2.8× 7 528
Susana Pérez-Álvarez Spain 9 81 0.3× 60 0.3× 101 0.6× 100 0.7× 88 0.7× 14 279
Mitsuyasu Rt United States 9 149 0.6× 82 0.4× 121 0.8× 111 0.8× 76 0.6× 12 349
Chike O. Abana United States 11 103 0.4× 74 0.4× 109 0.7× 56 0.4× 135 1.1× 17 339
Rebeka Bordi United States 8 115 0.5× 92 0.5× 249 1.6× 107 0.8× 441 3.6× 10 579
Heather R. Hensler United States 5 232 1.0× 199 1.0× 29 0.2× 56 0.4× 99 0.8× 7 333
Patrick Jourdan France 7 121 0.5× 65 0.3× 180 1.1× 28 0.2× 317 2.6× 7 418

Countries citing papers authored by Mark D. Weinstein

Since Specialization
Citations

This map shows the geographic impact of Mark D. Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Weinstein more than expected).

Fields of papers citing papers by Mark D. Weinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Weinstein. The network helps show where Mark D. Weinstein may publish in the future.

Co-authorship network of co-authors of Mark D. Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Weinstein. A scholar is included among the top collaborators of Mark D. Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Weinstein. Mark D. Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Ramesh I., et al.. (2025). Food-Dependent Exercise-Induced Anaphylaxis on a Nontraditional Timeline. Cureus. 17(6). e86854–e86854.
2.
Weinstein, Mark D., et al.. (2021). Rituximab as Treatment of Chronic Idiopathic Urticaria. Journal of Allergy and Clinical Immunology. 147(2). AB23–AB23. 1 indexed citations
3.
Weinstein, Mark D.. (2021). Vaccine Hesitancy is Focus on COVID-19 Podcast. DigitalCommons-Cedarville (Cedarville University). 1 indexed citations
4.
Weinstein, Mark D.. (2020). COVID-19 Brings Telehealth Services to Normal Health Care. DigitalCommons-Cedarville (Cedarville University). 1 indexed citations
5.
Jimenez, Melissa, et al.. (2019). The Effect of Zero Copayments on Medication Adherence in a Community Pharmacy Setting. SHILAP Revista de lepidopterología. 10(2). 16–16. 3 indexed citations
6.
Weinstein, Mark D.. (2019). Students Use Storytelling to Change Perceptions of Appalachia.
7.
Weinstein, Mark D.. (2017). Online Safety, Integrity Focus of CyberSecurity Presentation. DigitalCommons-Cedarville (Cedarville University).
8.
Weinstein, Mark D.. (2016). Stem Cell Donation Hopes to Bring Life to Australian Teen. DigitalCommons-Cedarville (Cedarville University).
9.
Johnson, Margaret, et al.. (2007). Results of a survey of biological drug and device industries inspected by FDA under the Team Biologics Program.. PubMed. 61(3). 211–22. 1 indexed citations
10.
Berger, Irina, Frank Autschbach, Mark D. Weinstein, et al.. (2005). Tissue-Resident Macrophages Are Productively Infected Ex Vivo by Primary X4 Isolates of Human Immunodeficiency Virus Type 1. Journal of Virology. 79(8). 5220–5226. 32 indexed citations
11.
Abbey, Nancy W., et al.. (2004). Expression of the Diffuse B-cell Lymphoma Family Molecule SWAP-70 in Human B-cell Neoplasms. Applied immunohistochemistry & molecular morphology. 12(1). 21–25. 7 indexed citations
12.
Jekle, Andreas, Oliver T. Keppler, Erik De Clercq, et al.. (2003). In Vivo Evolution of Human Immunodeficiency Virus Type 1 toward Increased Pathogenicity through CXCR4-Mediated Killing of Uninfected CD4 T Cells. Journal of Virology. 77(10). 5846–5854. 102 indexed citations
13.
Scott, Walter, et al.. (2001). The Pirate. Edinburgh University Press eBooks. 1 indexed citations
14.
Blackbourn, David J., Evelyne T. Lennette, Barbara Klencke, et al.. (2000). The restricted cellular host range of human herpesvirus 8. AIDS. 14(9). 1123–1133. 85 indexed citations
15.
Weinstein, Mark D.. (1999). Looking Back. Inquiry Critical Thinking Across the Disciplines. 18(4). 99–101. 1 indexed citations
16.
Cohen, Sandra, Andrew Blauvelt, Mark D. Weinstein, Brian Herndier, & Grant J. Anhalt. (1998). No Evidence of Human Herpesvirus 8 Infection in Patients with Paraneoplastic Pemphigus, Pemphigus Vulgaris, or Pemphigus Foliaceus. Journal of Investigative Dermatology. 111(5). 781–783. 27 indexed citations
17.
Orenstein, Jan M., Andrew Blauvelt, Kuan‐Teh Jeang, et al.. (1997). Visualization of human herpesvirus type 8 in Kaposiʼs sarcoma by light and transmission electron microscopy. AIDS. 11(5). F35–F45. 172 indexed citations
18.
Herndier, Brian, Bruce Shiramizu, Mark D. Weinstein, Don Ganem, & Jan M. Orenstein. (1997). KSHV LATENT AND LYTIC INFECTION IN KAPOSI'S SARCOMA LESIONS AND LYMPHOID TISSUE. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A25–A25. 1 indexed citations
19.
Weinstein, Mark D.. (1993). Weinstein, from page one. Inquiry Critical Thinking Across the Disciplines. 11(3). 16–22. 1 indexed citations
20.
Weinstein, Mark D.. (1990). Weinstein, from page 1. Inquiry Critical Thinking Across the Disciplines. 6(2). 19–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026